To investigate the levels of platelet reactivity and the impact of high platelet reactivity (HPR) on long-term clinical outcomes of complex higher-risk and indicated patients (CHIP) with stable coronary artery disease (CAD) treated with elective percutaneous coronary intervention (PCI).

Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients

Mangiacapra, Fabio;Spoto, Silvia;Di Sciascio, Germano;Ussia, Gian Paolo;Grigioni, Francesco
2022-01-01

Abstract

To investigate the levels of platelet reactivity and the impact of high platelet reactivity (HPR) on long-term clinical outcomes of complex higher-risk and indicated patients (CHIP) with stable coronary artery disease (CAD) treated with elective percutaneous coronary intervention (PCI).
Aged
Aspirin
Clopidogrel
Coronary Artery Disease
Female
Humans
Male
Myocardial Infarction
Platelet Aggregation
Platelet Aggregation Inhibitors
Prospective Studies
Purinergic P2Y Receptor Antagonists
Risk Assessment
Thrombosis
Percutaneous Coronary Intervention
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12610/67121
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact